ARCHIVE
LONDON
REGENERATIVE MEDICINE NETWORK - JANUARY 2006
MEETING
The January meeting of the London Regenerative Medicine
Network will be held in the evening of Thursday 19th
January at King's
College London (New Hunt's House Lecture Theatre 2, Guy's
Hospital Campus at London Bridge, London SE1). The meeting
will include presentations by Dr. Paul Kemp
(Ex-Organogenesis Inc. and now Founder and CSO of
Intercytex Ltd) one of the World's leading commercial
tissue engineers and Dr. Anne Bishop (Imperial) who is at
the forefront of producing lung cells from human embryonic
stem cells plus the launch of the new journal,
"Regenerative Medicine". All attendees of the Network event
will receive free on-line access to "Regenerative Medicine"
for a limited period of time!
Dr. Paul
Kemp - Founder + Chief
Scientific Officer - Intercytex Ltd - www.intercytex.com
Dr. Paul Kemp has been heavily involved in commercial
tissue engineering for over 20 years both in the U.S. and
the U.K. After post-doctoral research on the
biochemistry of collagen cross-links at Manchester
University, he joined Organogenesis Inc (Canton, MA, USA)
in late 1986. Organogenesis is the world’s
first tissue engineering company. Whilst at Organogenesis,
Paul was instrumental in the commercial development of
Apligraf which was to become the World's first FDA approved
tissue-engineered organ. Apligraf is tissue-engineered skin
which has now been used to treat over 100,000 patients
mainly in the U.S. for the treatment of chronic ulcers
(www.apligraf.com)
Paul whilst serving as Vice President, left Organogenesis
in 1997 to return to the UK. Two years later he founded
Intercytex Ltd. This company is devoted to the
cellular induction of human tissues and organs and has
products in hair and skin regeneration that are currently
undergoing clinical studies. Todate, Paul he has so far
developed three different cell-based products that have all
undergone successful clinical trials in North America and
Europe. Not only does Paul drive the science but he has
also successfully raised over £32 million pounds in venture
capital for Intercytex - definitely an all-round
entrepreneur!!!
Dr. Anne
Bishop - Reader - Tissue
Engineering and Regenerative Medicine (TERM) - Imperial
College London
The Respiratory Research Group at TERM was created in 2001
with the aim of producing cells and eventually tissue for
the repair, replacement and/or regeneration of diseased
lung. Anne is Leader of the Lung Group who are
attempting to develop creative ways to repair lung damaged
by diseases such as pulmonary hypertension and cystic
fibrosis. Anne and her team have achieved two world firsts
by successfully deriving lung cells (type II pneumocytes
which are the cells responsible for gaseous exchange)
initially from mouse stem cells and now more recently from
human embryonic stem cells. Whist there is still a long way
to go before whole lungs for transplantation can be tissue
engineered, these cells could also be potentially used to
repair parts of damaged lungs. For example, Anne and her
colleagues plan to use their findings to treat conditions
such as acute respiratory distress syndrome (ARDS) - a
condition which damages type II pneumocytes and which
currently kills many critically ill hospital patients.
http://news.bbc.co.uk/1/hi/health/4175822.stm
Currently the Imperial team together with NovaThera Ltd (an
Imperial College spin-out company) are working in close
collaboration with Novalung a German medtech company.
Novalung are interested in creating the World’s first
bio hybrid lung-assist device. This device is being
designed to contain stem cell-derived lung cells and
prolong the life of patients whose lungs have been damaged
by fire or illness until they recover or for those on
transplant waiting lists, whose lungs have ceased to
function, until a donor organ can be found.
http://wwwfom.sk.med.ic.ac.uk/medicine/people/a.e.bishop.html
http://www.novalung.com/en/index.php
"Regenerative
Medicine" Journal
Dr. Stephen Minger (Senior Editor) is Director of the Stem
Cell Biology Laboratory, Wolfson Centre for Age Related
Diseases, King's College London. In 2002, together with Dr
Susan Pickering and Professor Peter Braude, Stephen was
awarded one of the first two licenses granted by the Human
Fertilisation and Embryology Authority for the derivation
of human emybryonic stem (ES) cells. His group subsequently
generated the first human ES cell line in the UK and was
one of the first groups to deposit human ES cells into the
UK Stem Cell Bank.
http://www.futuremedicine.com/loi/rme
This meeting is free of charge to everyone through the
generous sponsorship of "Regenerative Medicine" journal,
the long-standing support of GlaxoSmithKline plus the kind
assistance of the London Biotechnology
Network.
PLEASE NOTE THAT DUE TO LECTURE THEATRE SEATING CAPACITY +
CATERING ARRANGEMENTS, IF YOU WISH TO ATTEND THIS EVENT YOU
MUST EMAIL THE SECRETARY, OTHERWISE UNFORTUNATELY YOU WILL NOT
BE ABLE TO GAIN ADMISSION. Seat allocation is on a first
come first served basis. If you wish to attend, all that
is required, is to email the Network Secretary (secretary@regenmednetwork.com) and
type "Please add me to the guest list for January -
Thank you" or something similar!!!
AGENDA:
18.00 - Registration over tea and coffee
18.30 - Welcome by - Dr. Chris Mason (UCL) - Co-organiser
of the Network
18.35 - Presentation 1 - "Lung tissue engineering" - Dr.
Anne Bishop - Reader - Tissue Engineering and Regenerative
Medicine (TERM) - Imperial College London
19.05 - Q+A Session
19.10 - Presentation 2 - "The history of tissue engineering
and regenerative medicine" - Dr. Paul Kemp - Founder +
Chief Scientific Officer - Intercytex Ltd.
19.40 - Q+A Session
19.45 - Launch of the "Regenerative Medicine" Journal -
Elisa Manzotti (Editorial Director) and Dr. Stephen Minger
(Senior Editor)
20.00 - Closing remarks - Dr. Stephen Minger (King's) -
Co-organiser of the Network
20.10 - 22.00 - Networking reception - enjoy a glass of
wine or two...
We look forward to seeing everyone on Thursday 19th
January for our first
event of 2006!
Stephen Minger + Chris Mason.
Co-organisers, London Regenerative Medicine Network.
www.regenmednetwork.com
PRINCIPLE
SPONSORS
Guy's, King's and St Thomas' Annual
Fund
London
Regenerative Medicine Network
"Bringing the regenerative medicine, stem cell and tissue
engineering community together..."